Skip to main content
Boston Scientific10-Q: Product launch

Strong sales growth driven by Farapulse, AGENT, and Intracept products.

What happened

BSX is experiencing significant growth driven by key products like the Farapulse™ PFA System, AGENT™ Drug-Coated Balloon, and Intracept™ system. This success creates budget and focus for sales, marketing, and supply chain support for these high-growth franchises.

Source

SEC EDGARMay 1, 2026

Quarterly report (Form 10-Q)

Boston Scientific 10-Q

Filing excerpt

In the first quarter of 2026, reported net sales growth was primarily driven by our comprehensive pain portfolio, led by our Intracept™ Intraosseous Nerve Ablation System and Nalu Peripheral Nerve Stimulation System...

sec.gov/Archives/edgar/data/885725/000088572526000033/bsx-20260331.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Product launch

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
03/31
Filed
May 1, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
885725
Accession number
0000885725-26-000033
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Go-to-market support
Signal category
Strategic

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
May 5, 2026
signal_type
sec-10q
signal_subtype
productLaunch

Use this data

Get every 10-Q signal for Boston Scientific and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/c2f27b0d-06b7-4111-a9de-6b430a315e91 returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.

{
  "signal_id": "c2f27b0d-06b7-4111-a9de-6b430a315e91",
  "signal_type": "sec-10q",
  "signal_subtype": "productLaunch",
  "detected_at": "2026-05-05T08:48:22.54+00:00",
  "company": {
    "name": "Boston Scientific",
    "domain": "bostonscientific.com"
  },
  "data": {
    "detail": "BSX is experiencing significant growth driven by key products like the Farapulse™ PFA System, AGENT™ Drug-Coated Balloon, and Intracept™ system. This success creates budget and focus for sales, marketing, and supply chain support for these high-growth franchises.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "Strong sales growth driven by Farapulse, AGENT, and Intracept products.",
    "excerpts": "In the first quarter of 2026, reported net sales growth was primarily driven by our comprehensive pain portfolio, led by our Intracept™ Intraosseous Nerve Ablation System and Nalu Peripheral Nerve Stimulation System...",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000033/bsx-20260331.htm",
    "filing_date": "2026-05-01",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Go-to-market support",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.